Cerevel Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch CERE and buy or sell other stocks, ETFs, and their options commission-free!About CERE
Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease.
CEORonald C. Renaud, Jr., MBA
CEORonald C. Renaud, Jr., MBA
Employees—
Employees—
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2018
Founded2018
Employees—
Employees—
CERE Key Statistics
Market cap8.19B
Market cap8.19B
Price-Earnings ratio-16.46
Price-Earnings ratio-16.46
Dividend yield—
Dividend yield—
Average volume2.06M
Average volume2.06M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$44.99
52 Week high$44.99
52 Week low$19.59
52 Week low$19.59
Stock Snapshot
Cerevel Therapeutics(CERE) stock is priced at $44.96, giving the company a market capitalization of 8.19B. It carries a P/E multiple of -16.46.
Cerevel Therapeutics(CERE) stock opened on 2025-11-16 at —. The price climbed to — and dipped to —.
The Cerevel Therapeutics(CERE)'s current trading volume is 0, compared to an average daily volume of 2.06M.
In the last year, Cerevel Therapeutics(CERE) shares hit a 52-week high of $44.99 and a 52-week low of $19.59.
In the last year, Cerevel Therapeutics(CERE) shares hit a 52-week high of $44.99 and a 52-week low of $19.59.
People also own
Based on the portfolios of people who own CERE. This list is generated using Robinhood data, and it’s not a recommendation.